{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:11:40Z","timestamp":1769551900711,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.brainres.2013.01.054","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T16:46:08Z","timestamp":1360773968000},"page":"68-74","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism"],"prefix":"10.1016","volume":"1505","author":[{"given":"Mohammadreza","family":"Jalali-Nadoushan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.01.054_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neures.2011.08.008","article-title":"Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of alpha-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity","volume":"71","author":"Abdin","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbi.2009.08.013","article-title":"Modulatory role of lipoic acid on lipopolysaccharide-induced oxidative stress in adult rat Sertoli cells in vitro","volume":"182","author":"Aly","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.brainres.2013.01.054_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.neuint.2012.09.003","article-title":"The oxidative damage and inflammation caused by pesticides are reverted by lipoic acid in rat brain","volume":"61","author":"Astiz","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2013.01.054_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.01.054_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2011.06.007","article-title":"Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress","volume":"224","author":"Baluchnejadmojarad","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainres.2013.01.054_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2010.12.002","article-title":"Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis","volume":"233","author":"Chaudhary","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2013.01.054_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mjt.0000174353.28012.a7","article-title":"Neuroprotective therapy in Parkinson disease","volume":"13","author":"Chen","year":"2006","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.brainres.2013.01.054_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2008.11.025","article-title":"Distribution study of orally administered lipoic acid in rat brain tissues","volume":"1251","author":"Chng","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2011.11.047","article-title":"Co-administration of apocynin with lipoic acid enhances neuroprotection in a rat model of ischemia\/reperfusion","volume":"507","author":"Connell","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.01.054_bib38","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neuro.2011.01.003","article-title":"alpha-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease","volume":"32","author":"Covy","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2013.01.054_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00207454.2010.535934","article-title":"The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review","volume":"121","author":"De Araujo","year":"2011","journal-title":"Int. J. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.brainres.2013.01.054_bib40","doi-asserted-by":"crossref","first-page":"II82","DOI":"10.1007\/PL00007766","article-title":"Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease","volume":"247","author":"Foley","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2013.01.054_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.01.081","article-title":"Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1","volume":"1206","author":"Fujita","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib42","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/NRL.0b013e31823966b4","article-title":"Initial motor symptoms of Parkinson disease","volume":"17","author":"Garcia Ruiz","year":"2011","journal-title":"Neurologist"},{"key":"10.1016\/j.brainres.2013.01.054_bib43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","article-title":"Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway","volume":"62","author":"Guo","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2013.01.054_bib44","first-page":"241","article-title":"Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease","volume":"44","author":"Hattori","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.brainres.2013.01.054_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","article-title":"Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis","volume":"4","author":"Henchcliffe","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.brainres.2013.01.054_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pharmthera.2006.07.001","article-title":"Lipoic acid as a novel treatment for Alzheimer's disease and related dementias","volume":"113","author":"Holmquist","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2013.01.054_bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1271\/bbb.110842","article-title":"Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons","volume":"76","author":"Hwang","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.brainres.2013.01.054_bib48","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00702-011-0698-2","article-title":"Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation","volume":"118","author":"Iravani","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2013.01.054_bib49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2013.01.054_bib50","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","article-title":"Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease","volume":"60","author":"Maczurek","year":"2008","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.brainres.2013.01.054_bib51","first-page":"535","article-title":"Lipoic acid: characteristics and therapeutic application","volume":"59","author":"Malinska","year":"2005","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.brainres.2013.01.054_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.01.054_bib53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pbb.2009.03.008","article-title":"Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro","volume":"92","author":"Mu","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2013.01.054_bib54","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.brainres.2013.01.054_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11010-010-0547-x","article-title":"Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid","volume":"344","author":"Pederzolli","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.brainres.2013.01.054_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresbull.2010.06.004","article-title":"Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism","volume":"82","author":"Roghani","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2013.01.054_bib57","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.0b013e3181990438","article-title":"Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease","volume":"72","author":"Schapira","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.01.054_bib58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2013.01.054_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib60","first-page":"689","article-title":"Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions","volume":"18","author":"Schwarting","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2013.01.054_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(87)90885-7","article-title":"A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation","volume":"426","author":"Shapiro","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.01.054_bib62","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/13543784.17.6.827","article-title":"Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?","volume":"17","author":"Soczynska","year":"2008","journal-title":"Expert Opin. Invest.Drugs"},{"key":"10.1016\/j.brainres.2013.01.054_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","article-title":"Divergent roles for tumor necrosis factor-alpha in the brain","volume":"2","author":"Sriram","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2013.01.054_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WNF.0b013e3181de8924","article-title":"Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio)","volume":"33","author":"Stocchi","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2013.01.054_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson's disease","volume":"73","author":"Von Bohlen und Halbach","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2013.01.054_bib66","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/NRL.0b013e31823966c6","article-title":"Assessment of Parkinson disease: what do we need to show neuroprotection?","volume":"17","author":"Ybot-Gorrin","year":"2011","journal-title":"Neurologist"},{"key":"10.1016\/j.brainres.2013.01.054_bib67","first-page":"65","article-title":"Effect of alpha-lipoic acid on the apoptosis of PC12 cells induced by 6-hydroxydopamine","volume":"34","author":"Yuan","year":"2001","journal-title":"Shi Yan Sheng Wu Xue Bao"},{"key":"10.1016\/j.brainres.2013.01.054_bib68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-l-carnitine and alpha-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy","volume":"100","author":"Zaitone","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2013.01.054_bib69","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/sj.npp.1301381","article-title":"Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation","volume":"32","author":"Zhou","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313001959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313001959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T14:58:04Z","timestamp":1539874684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313001959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"alternative-id":["S0006899313001959"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.01.054","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}